The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer

MLA

Yue Pan, et al. “The Key to Immunotherapy: How to Choose Better Therapeutic Biomarkers for Patients with Non-Small Cell Lung Cancer.” Biomarker Research, vol. 10, no. 1, Mar. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40364-022-00355-7.

APA

Yue Pan, Yucheng Fu, Yue Zeng, Xiaohan Liu, Yurong Peng, Chunhong Hu, Chao Deng, Zhenhua Qiu, Jian Zou, Yuxuan Liu, & Fang Wu. (2022). The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer. Biomarker Research, 10(1), 1–12. https://doi.org/10.1186/s40364-022-00355-7

Chicago

Yue Pan, Yucheng Fu, Yue Zeng, Xiaohan Liu, Yurong Peng, Chunhong Hu, Chao Deng, et al. 2022. “The Key to Immunotherapy: How to Choose Better Therapeutic Biomarkers for Patients with Non-Small Cell Lung Cancer.” Biomarker Research 10 (1): 1–12. doi:10.1186/s40364-022-00355-7.